Courier Therapeutics Competitors and Similar CompaniesClear all

Courier Therapeutics's competitors and similar companies include Agios Pharmaceuticals, Accent Therapeutics and ABL Bio.
Courier Therapeutics
Courier Therapeutics
Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Accent Therapeutics
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.
ABL Bio
ABL Bio
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
Founding Date
Founding Date
2015
Founding Date
2008
Founding Date
2017
Founding Date
2016
Type
Type
Private
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Houston, US HQ
Houston, US
Locations
Cambridge, US HQ
Locations
Lexington, US HQ
Locations
HQ
Employees
Employees
1
Employees
53611% increase
Employees
555% decrease
Employees
56

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 63m (over 4 years ago)
Latest funding round
$ 65m (over 6 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 103m
Total funding raised
$ 90.8m
For sources of this data, please see the company profile

View Company Profiles

Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
Accent Therapeutics
HQ
Lexington, US
Employees
55↓ 5% decrease

Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.

View company
ABL Bio
HQ
Employees
56

ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.

View company